Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
12.31
-0.37 (-2.92%)
Apr 28, 2026, 3:04 PM CST

SHE:300406 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
1,3711,3561,6481,7371,5081,598
Other Revenue
--11.284.42.881
1,3711,3561,6591,7421,5111,599
Revenue Growth (YoY)
-13.52%-18.29%-4.75%15.27%-5.53%88.58%
Cost of Revenue
279.12279.92361.88445.01384.12448.5
Gross Profit
1,0911,0761,2971,2971,1271,151
Selling, General & Admin
405.35408.88457.67491.04457.36444.38
Research & Development
179.28181.73188.53162.9137.2127.01
Other Operating Expenses
9.6110.1915.4514.9712.8512.92
Operating Expenses
594.23600.81665.03692.35625.46602.71
Operating Income
497.16474.78632.01604.27501.29548.17
Interest Expense
---47.61-46.99-52.64-21.59
Interest & Investment Income
15.812.1419.8225.9521.4815.74
Currency Exchange Gain (Loss)
---0.1-0.122.21-0.29
Other Non Operating Income (Expenses)
-67.94-67.032.39-3.5-28.33-19.94
EBT Excluding Unusual Items
445.01419.88606.52579.62444.01522.09
Impairment of Goodwill
-----3.03-
Gain (Loss) on Sale of Investments
0.15-----
Gain (Loss) on Sale of Assets
-2.2-2.87-2.11-3.5-2.680.16
Asset Writedown
-180.76-180.76-1.38-0.21-2.29-0.11
Other Unusual Items
--17.6617.6413.3514.85
Pretax Income
262.21236.25620.69593.55449.35536.99
Income Tax Expense
49.6445.7189.5371.4854.8967.33
Earnings From Continuing Operations
212.58190.54531.16522.07394.46469.66
Minority Interest in Earnings
-0.35-0.661.471.67-5.37-64.01
Net Income
212.22189.87532.64523.74389.1405.65
Net Income to Common
212.22189.87532.64523.74389.1405.65
Net Income Growth
-57.63%-64.35%1.70%34.60%-4.08%261.30%
Shares Outstanding (Basic)
591593579582581588
Shares Outstanding (Diluted)
591593592595614588
Shares Change (YoY)
-1.95%0.26%-0.56%-3.00%4.37%7.25%
EPS (Basic)
0.360.320.920.900.670.69
EPS (Diluted)
0.360.320.900.880.670.69
EPS Growth
-56.79%-64.44%2.27%31.47%-2.99%236.88%
Free Cash Flow
558.46525.87546.36437.06299.69275.9
Free Cash Flow Per Share
0.940.890.920.730.490.47
Dividend Per Share
--0.4000.2000.1000.100
Dividend Growth
--100.00%100.00%-0.66%
Gross Margin
79.63%79.35%78.19%74.45%74.58%71.96%
Operating Margin
36.27%35.03%38.10%34.70%33.18%34.27%
Profit Margin
15.48%14.01%32.11%30.07%25.75%25.36%
Free Cash Flow Margin
40.75%38.80%32.93%25.09%19.84%17.25%
EBITDA
567.6544.87700.68658.03554.35590.51
EBITDA Margin
41.41%40.20%42.24%37.78%36.69%36.92%
D&A For EBITDA
70.4570.0968.6753.7653.0542.33
EBIT
497.16474.78632.01604.27501.29548.17
EBIT Margin
36.27%35.03%38.10%34.70%33.18%34.27%
Effective Tax Rate
18.93%19.35%14.42%12.04%12.22%12.54%
Revenue as Reported
--1,6591,742-1,599
Advertising Expenses
--153.01194.01200.07186.98
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.